Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,743,613
+$4,985,943 QoQ
Shares Held
2,763,776
+115.4% QoQ
Ownership
0.801%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,382,181,502 across 180 Biotechnology names. ALLO ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in ALLO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,743,613 | 2,763,776 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,757,670 | 1,282,971 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $575,233 | 463,898 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $116,120 | 54,517 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $252,910 | 90,325 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $559,793 | 240,255 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $875,127 | 195,778 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $242,804 | 75,640 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $393,834 | 124,238 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,370,964 | 275,848 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,532,619 | 512,676 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,152,575 | 660,187 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,748,706 | 439,695 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,234,077 | 283,691 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,974,288 | 985,103 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,904,839 | 529,815 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $583,595 | 22,708 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,275,019 | 202,263 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $243,568 | 6,459 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||